thiazoles has been researched along with DRESS Syndrome in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, TY; Kim, EJ; Kim, MS; Kim, SW; Lee, JH; Son, SJ | 1 |
| Bean, JR; Lister, JF; Thimothy, L; Voinov, B | 1 |
| Chan, VC; Diak, IL; La Grenade, L; Levin, RL | 1 |
4 other study(ies) available for thiazoles and DRESS Syndrome
| Article | Year |
|---|---|
Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Hypersensitivity Syndrome; Female; Humans; Piperazines; Recurrence; Retreatment; Thiazoles | 2014 |
Drug-Induced Systemic Hypersensitivity Reaction Associated With Ziprasidone: An Atypical Occurrence.
Topics: Antipsychotic Agents; Drug Hypersensitivity Syndrome; Humans; Male; Middle Aged; Piperazines; Thiazoles | 2015 |
Febuxostat (Adenuric). Toxic epidermal necrolysis and severe hypersensitivity reactions added to the EU SPC.
Topics: Drug Hypersensitivity Syndrome; Febuxostat; Gout Suppressants; Humans; Risk Assessment; Risk Factors; Severity of Illness Index; Stevens-Johnson Syndrome; Thiazoles | 2015 |
US Food and Drug Administration warning about the risk of drug reaction with eosinophilia and systemic symptoms with ziprasidone.
Topics: Adverse Drug Reaction Reporting Systems; Antipsychotic Agents; Drug Hypersensitivity Syndrome; Humans; Piperazines; Thiazoles; United States; United States Food and Drug Administration | 2015 |